The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Hims & Hers Health Inc shares valued at $173,254 were sold by Baird Melissa on Apr 08 ’24. At $14.74 per share, Baird Melissa sold 11,751 shares. The insider’s holdings dropped to 538,932 shares worth approximately $7.87 million following the completion of this transaction.
Also, Baird Melissa sold 11,751 shares, netting a total of over 171,372 in proceeds. Following the sale of shares at $14.58 each, the insider now holds 538,932 shares.
Before that, Dudum Andrew had sold 188,888 shares from its account. In a trade valued at $2,828,075, the Chief Executive Officer traded Hims & Hers Health Inc shares for $14.97 each. Upon closing the transaction, the insider’s holdings decreased to 188,888 shares, worth approximately $0.0.
As published in their initiating research note from Canaccord Genuity on April 10, 2024, Hims & Hers Health Inc [HIMS] has been a Buy and the price target has been revised to $20. Analysts at Imperial Capital upgraded the stock from ‘”an In-line”‘ to ‘”an Outperform”‘ outlook in a report released in late February. As of February 26, 2024, Leerink Partners has initiated its “Market perform” rating for HIMS. Earlier on December 07, 2023, Imperial Capital initiated its rating. Their recommendation was “an In-line” for HIMS stock.
Analyzing HIMS Stock Performance
During the last five days, there has been a drop of approximately -0.54%. Over the course of the year, Hims & Hers Health Inc shares have jumped approximately 64.04%. Shares of the company reached a 52-week high of $17.16 on 03/25/24 and a 52-week low of $8.09 on 01/05/24. A 50-day SMA is recorded $12.94, while a 200-day SMA reached $8.96. Nevertheless, trading volume fell to 2.97 million shares from 3.91 million shares the previous day.
Support And Resistance Levels for Hims & Hers Health Inc (HIMS)
According to the 24-hour chart, there is a support level at 14.43, which, if violated, would cause prices to drop to 14.27. In the upper region, resistance lies at 14.76. The next price resistance is at 14.92. RSI (Relative Strength Index) is 50.96 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at -0.69, which suggests the price will decrease in the coming days. Percent R is at 86.49%, indicating bearish price movement. Stochastics %K at buying indicates that the stock is to be held.
Is Hims & Hers Health Inc subject to short interest?
Stocks of Hims & Hers Health Inc saw a sharp steep in short interest on Mar 15, 2024 dropping by -0.71 million shares to 12.76 million. Data from Yahoo Finance shows that the short interest on Feb 15, 2024 was 13.47 million shares. A decline of -5.56% in short interest reflects a positive sentiment towards the stock. Despite the fact that short shares comprise just 1.71 of the overall float, the days-to-cover ratio (short ratio) decline to 1.71.
